Page 22 - GTM-2-2

Global Translational Medicine Use of cardio biomarker in diagnosis of AMI

as cancer, ischemia, myocardial infarction, and dilated oxide emission. PaPPA has been found to be a repair-
cardiomyopathy. promoting and inflammation-responsive protein in other
[30]
The majority of MMPs are produced as zymogens and injured tissues .
secreted in this manner, but there is also a subfamily that 4.5. Adrenomedullin
is membrane-bound (membrane-type MMPs) . Tissue
[26]
inhibitors of metalloproteinases (TIMPs), which belong The kidneys, lungs, adrenal medulla, heart, and liver
to a class of tightly binding, naturally occurring proteins, express adrenomedullin (ADM), which is a peptide with
control the activity of MMPs . Long-term remodeling 52 amino acids. It advances within the heart and also
[27]
activities, including embryogenesis, inflammation, tumor uses natriuretic peptides (NPs) in response to volume
[31]
invasion, angiogenesis, and wound healing, are all facilitated and pressure overload . It has a potent diuretic and
by MMPs. Recent research has revealed that MMP-2 (also natriuretic effect and is a powerful vasodilator. ADM levels
known as gelatinase A or type IV collagenase) performs a in plasma are markedly increased in heart failure and
combination of cellular activities rapidly (within seconds AMI, connected to the seriousness of the condition, and of
[32]
to minutes), which impacts the ECM. Using mice model prognostic significance in AMI-related death .
in which MMP gene has been deleted, it has also been 4.6. Troponin
revealed that MMP-2 and MMP-9 play an important role
in the increase in aneurysms of the abdominal aorta. Both Greaser and Gergely demonstrated in 1971 that the
MMP-2 and MMP-9 degrade type I and type II interstitial troponin complex is composed of three components.
collagen, type III and type IV collagen, elastin, and other Due to their distinct features, these sections were given
ECM components. The digestion of the intercellular MMP- the designations TnC, TnI, and TnT. TnC has the binding
2, troponin I, myosin light chain, and poly(ADP-ribose) capacity for Ca2+; TnI possesses the ability to inhibit
[33]
polymerase present in cardiomyocytes may be a factor in ATPase activity; and TnT binds to tropomyosin .
cardiac dysfunction . Troponin C is produced in both cardiac and skeletal
[26]
muscle. Troponin T and I isoforms are known as
4.3. Inflammation cardiac troponins due to their heightened sensitivity to
Inflammation is a commonplace in AMI due to tissue loss and specificity for cardiac myocytes (cTn). As a result,
and cell death in the heart. Pro-inflammatory cytokines, identifying cTn-T or cTn-I in the blood is a very reliable
chemokines, and other inflammatory mediators are way to detect cardiac damage .
[8]
produced at the site of injury, attracting immune cells, and
causing extra tissue damage and inflammation. Surgery 4.7. Creatinine kinase
may aggravate the symptoms of initial ischemia and An enzyme called CK, also known as creatine
worsen the AMI patients’ prognosis. Biomarkers such as phosphokinase (CPK), is present in many different tissues.
tumor necrosis factor-alpha (TNF-α), interleukin (IL)- CK is expressed in skeletal muscle, heart, and brain and
6, and CRP are associated with inflammation in cases of is a cardiac-specific enzyme with a clinical sensitivity of
AMI. Increasing concentrations of these biomarkers are 90% for detecting AMI, but it has low specificity. The time
associated with an increased risk of adverse cardiovascular required for CK to reach the peak is 20–30 h and the time
events, such as recurrent myocardial infarction, heart of return to the normal level is 24–48 h. A result, CK is
failure, and death . ineffective in the quick identification of AMI .
[28]
[34]
4.4. Pregnancy-associated plasma protein A 4.8. C-terminal pro-arginine vasopressin
The ECM of unstable plaques contains high levels of C-terminal pro-arginine vasopressin (copeptin), a more
pro-atherosclerotic metalloproteinase and pregnancy- stable alternative to arginine vasopressin, is well known
associated plasma protein A (PaPPA) . Circulating for its effects on the harmony of the cardiovascular and
[28]
PaPPA was observed in patients with unstable angina endocrine systems . In the development of AMI, it is
[35]
and significantly increased AMI, which is correlated with believed that vasopressin encourages expansion afterload,
troponin, but not with growth factors or CRPs similar to peripheral vasoconstrictor activity, and ventricular stress.
insulin. PaPPA >2.9 mlU/L predicts a 4.6-fold increase in Myocyte protein expression then rises, resulting in
the risk of cardiovascular mortality, myocardial infarction, hypertrophy and vasoconstriction of the coronary arteries.
or revascularization even in the absence of elevated The V1 receptor mediates these effects, whereas actions
troponin levels . When it binds to the binding sites on on the V2 receptor cause the renal tubules to retain water.
[29]
endothelium, endothelial dysfunction can be reversed by The current focus of pharmaceutical therapy is on these
cleaving insulin-like growth factor-1, causing the nitric receptors [36,37] .

Volume 2 Issue 2 (2023) 4 https://doi.org/10.36922/gtm.0403